Literature DB >> 16595516

Polyarteritis nodosa when applying the Chapel Hill nomenclature--a descriptive study on ten patients.

D Selga1, A Mohammad, G Sturfelt, M Segelmark.   

Abstract

OBJECTIVES: Polyarteritis nodosa (PAN) is a term that has been used to describe a wide variety of vasculitic conditions. In 1994, the Chapel Hill Consensus Conference on the nomenclature of systemic vasculitides proposed that the name classical PAN should be restricted to diseases where there is arteritis in small and medium-sized arteries without the involvement of smaller vessels. Our aim was to describe the symptoms and course of disease in PAN when the microscopic forms are excluded.
METHODS: All patients with a diagnosis of PAN treated in our departments during the period 1990-2002 were eligible for this study. The diagnosis had to be confirmed by biopsy, angiography or electromyography.
RESULTS: Ten patients were eligible for the study. The median age was 46 yrs. Renal involvement was seen in 70% at diagnosis. After 5 yrs, 57% had experienced a relapse, which is equivalent to the relapse rate seen in microscopic polyangiitis. Organ damage was assessed by the Vasculitis Damage Index (VDI) and after 5 yrs cardiovascular and neuropsychiatric damage dominated, followed by renal damage. During the follow-up, two patients developed end-stage renal disease. The annual incidence of PAN in our local catchment area was estimated to 1.6 per million and year.
CONCLUSIONS: When applying the Chapel Hill nomenclature, PAN is a rare but severe disease with a high incidence of renal involvement and frequent relapses.

Entities:  

Mesh:

Year:  2006        PMID: 16595516     DOI: 10.1093/rheumatology/kel091

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  7 in total

1.  Diagnosis and treatment of cerebral vasculitis.

Authors:  Peter Berlit
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

2.  Polyarteritis nodosa mimicking peripheral vascular disease.

Authors:  Ingrid Boehm
Journal:  J Gen Intern Med       Date:  2008-12       Impact factor: 5.128

Review 3.  Infliximab for the treatment of refractory polyarteritis nodosa.

Authors:  Shira Ginsberg; Itzhak Rosner; Gleb Slobodin; Michael Rozenbaum; Lisa Kaly; Nizar Jiries; Nina Boulman; Abid Awisat; Haya Hussein; Irina Novofastovski; Amal Silawy; Doron Rimar
Journal:  Clin Rheumatol       Date:  2019-04-10       Impact factor: 2.980

4.  Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies.

Authors:  Richard Watts; Suzanne Lane; Thomas Hanslik; Thomas Hauser; Bernhard Hellmich; Wenche Koldingsnes; Alfred Mahr; Mårten Segelmark; Jan W Cohen-Tervaert; David Scott
Journal:  Ann Rheum Dis       Date:  2006-08-10       Impact factor: 19.103

5.  Isolated panniculitis with vasculitis of the male breast suspicious for malignancy on CT and ultrasound: a case report and literature review.

Authors:  Wei-Hsin Yuan; Anna Fen-Yau Li; Hui-Chen Hsu; Yi-Hong Chou
Journal:  Springerplus       Date:  2014-10-30

6.  Relationship Between Cerebrovascular Diseases and Vasculitis: A Cross-Sectional Nationwide Inpatient Study.

Authors:  Johanna S Canenguez Benitez; Sanobar Jaka; Nikhita S Roshan; Sravani Kommuru; Samreen Ahmed; Gagan Kaur; Ninad Desai
Journal:  Cureus       Date:  2022-07-29

Review 7.  Remission of Angiographically Confirmed Minocycline-induced Renal Polyarteritis Nodosa: A Case Report and Literature Review.

Authors:  Kenichi Yokota; Isao Kurihara; Toshifumi Nakamura; Seishi Nakatsuka; Kazutoshi Miyashita; Sakiko Kobayashi; Ayano Murai-Takeda; Masakatsu Sone; Hiroshi Itoh
Journal:  Intern Med       Date:  2021-06-26       Impact factor: 1.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.